Skip to main content

Pfizer company profile

  • PFE · NYSE
  • Pharmaceuticals
  • S&P 500
$28.89+0.21%Close 13 Nov 2026

About Pfizer

Pfizer Inc. is a research-based, global biopharmaceutical company that discovers, develops, manufactures, markets, sells and distributes biopharmaceutical products. Its Biopharma segment, the only reportable segment, covers medicines and vaccines across oncology, internal medicine, vaccines, and inflammation and immunology, including biosimilars and off-patent sterile injectables. The company sells to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies, and its vaccines are sold in the U.S. primarily to the federal government. Pfizer operates across developed and emerging markets and supplies its medicines and vaccines to approximately 200 countries and territories. Revenues from outside the U.S. were $25.5 billion in 2025.

A summary of the business section of the company's latest annual report, filed 26 Feb 2026.

Company facts

TickerPFE · NYSE
SectorPharmaceuticals
IndustryPharmaceuticals
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK78003
Latest annual report10-K, filed 26 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Albert Bourla, DVM, Ph.D.Chairman & CEO · Director379K · < 1%Open-market purchase, 12 Aug 2026
Douglas M. LanklerExecutive Vice President161K · < 1%Shares withheld for tax, 25 Feb 2026
Ronald E. BlaylockDirector32.5K · < 1%Open-market purchase, 5 Aug 2026
Mortimer J. BuckleyDirector0 · < 1%Open-market purchase, 5 Aug 2026
DAMICO JENNIFER B.SVP & Controller—Open-market sale, 5 Aug 2026
McDermott MichaelExecutive Vice President—Shares withheld for tax, 26 Feb 2026
SAHNI PAYALExecutive Vice President—Shares withheld for tax, 25 Feb 2026
Fonseca LidiaExecutive Vice President—Option exercise, 25 Feb 2026
BOSHOFF CHRISTOFFELPresident, R&D—Shares withheld for tax, 25 Feb 2026
SUSMAN SALLYExecutive Vice President—Option exercise, 27 Feb 2025

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

PFE in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.